Please enable Javascript to get a taste of that Hopium 👼

ADVM - Company Overview - Adverum Biotechnologies Inc
Adverum Biotechnologies Inc
NASDAQ: advm

$1.39

USD

-$0.03

-2.11%

Prev Close

$1.42

Today's Open

$1.42

Volume

0.00

Market Cap

136.43M

Day Range

1.37

range triangle

1.44

52W Range

1.37

range triangle

13.88

Overview

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for ADVM. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

-1.52

P/E Ratio

0

Price to Sales

18.45

Price to Book

0.423

Profit Ratios

Profit Margin

0.00%

EBITDA Margin

-796.59%

Net Profit Margin

-977.45%

ROA

-18.40%

Total Revenue

$7.50M

Net Profit

-$73.31M

EV to EBITDA

0.446

EV to Revenue

3.7006K

Data source(s): Alpha Vantage